Chimeric CYP21A1P/CYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia

Warning

This publication doesn't include Faculty of Sports Studies. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	VRZALOVÁ Zuzana HRUBÁ Zuzana HRABINCOVÁ Eva VRÁBELOVÁ Slávka VOTAVA Felix KOLOUŠKOVÁ Stanislava FAJKUSOVÁ Lenka
Year of publication	2011
Type	Article in Periodical
Magazine / Source	European Journal of Medical Genetics
MU Faculty or unit	Central European Institute of Technology
Citation
Doi	http://dx.doi.org/10.1016/j.ejmg.2010.10.005
Field	Genetics and molecular biology
Keywords	Congenital adrenal hyperplasia; chimeric gene
Description	Congenital adrenal hyperplasia (CAH) comprises a group of autosomal recessive disorders caused by an enzymatic deficiency which impairs the biosynthesis of cortisol and, in the majority of severe cases, also the biosynthesis of aldosterone. Approximately 95% of all CAH cases are caused by mutations in the steroid 21-hydroxylase gene (CYP21A2). The CYP21A2 gene and its inactive pseudogene (CYP21A1P) are located within the HLA class III region of the major histocompatibility complex (MHC) locus on chromosome 6p21.3.
Related projects:	Molecular basis of cell and tissue regulations Integrované bioanalytické technologie pro mikroanalýzy a diagnostiku s využitím LIF a hmotnostní spektrometrie